2009
DOI: 10.1016/j.carres.2008.11.009
|View full text |Cite
|
Sign up to set email alerts
|

Novel easily accessible glucosidase inhibitors: 4-hydroxy-5-alkoxy-1,2-cyclohexanedicarboxylic acids

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
30
0

Year Published

2009
2009
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 26 publications
(31 citation statements)
references
References 52 publications
1
30
0
Order By: Relevance
“…Its inhibitors are be used to treat diabetics, HIV and cancers [3,4]. Clinical trials showed that the α-glucosidase inhibitors improved long-term glycemic control as measured by decreased hemoglobin A1c (HbA1c) in patients with type II diabetes and delayed the development of type II diabetes in patients with impaired glucose tolerance [5]. Recently, there had been widespread interest in α-glucosidase inhibitors, partly because of their potential as therapeutic targets, especially the inhibition of these enzymes had been found to help control postprandial blood glucose levels in diabetic patients [6,7], and can have profound effects on maturation, transport, and secretion of glycoproteins and can alter cell-cell recognition processes [8][9][10].…”
Section: Introdcutionmentioning
confidence: 99%
“…Its inhibitors are be used to treat diabetics, HIV and cancers [3,4]. Clinical trials showed that the α-glucosidase inhibitors improved long-term glycemic control as measured by decreased hemoglobin A1c (HbA1c) in patients with type II diabetes and delayed the development of type II diabetes in patients with impaired glucose tolerance [5]. Recently, there had been widespread interest in α-glucosidase inhibitors, partly because of their potential as therapeutic targets, especially the inhibition of these enzymes had been found to help control postprandial blood glucose levels in diabetic patients [6,7], and can have profound effects on maturation, transport, and secretion of glycoproteins and can alter cell-cell recognition processes [8][9][10].…”
Section: Introdcutionmentioning
confidence: 99%
“…The preliminary tests against fungal glycosidases revealed only a weak to moderate inhibition of β-D-glucosidase by compounds 125 (R = H) and 127+128 (R = CH 3 , n-C 6 H 13 ), and a weak inhibition of α-L-fucosidase by compounds 125+126, and 127+128 (R = CH 3 , n-C 6 H 13 ). 111,155,156 However, very promising results were obtained for cyclohexanedicarboxylic acids of types 129-131. 111,[155][156][157][158] The synthesis of compounds 129-131…”
Section: 155-158mentioning
confidence: 99%
“…111,155,156 However, very promising results were obtained for cyclohexanedicarboxylic acids of types 129-131. 111,[155][156][157][158] The synthesis of compounds 129-131…”
Section: 155-158mentioning
confidence: 99%
See 1 more Smart Citation
“…-Glucosidase ( -D-glucoside glucohydrolase, EC 3.2.1.20) catalyses the release of D-glucose residues from the non-reducing end of a variety of substrates, including disaccharides, oligosaccharides and aryl-and alkyl--glucopyranosides (Zdzieb and Synowiecki, 2002;Brazdova et al, 2009). Thermostable -glucosidases isolated from a variety of microorganisms are suitable for the improvement of industrial starch processing into glucose syrup.…”
Section: Introductionmentioning
confidence: 99%